Latest news with #PrashantJain
Time of India
11-07-2025
- Business
- Time of India
Glenmark Pharmaceuticals shares rally up to 20%, mutual funds lead the charge over retail investors
The shares of Glenmark Pharmaceuticals surged 20% on Friday, July 11, to a day's high of Rs 2,286 following a landmark $2 billion licensing deal with U.S. pharma giant AbbVie for its cancer drug, ISB 2001. While the announcement caught the attention of retail investors, the real winners were India's top mutual funds . pradee According to the data on BSE, mutual fund holdings in Glenmark Pharma rose from 9.11% in June 2023 to 14.60% by March 2025 (the last available data). Best MF to invest Looking for the best mutual funds to invest? Here are our recommendations. View Details » by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Live by the Beach at Sunteck's 2/3BHK Homes starts @₹98L+ Sunteck Realty Learn More Undo Also Read | Investors' pour Rs 47,000 crore in midcap & smallcap mutual funds in H1 CY25. What are they really chasing? Promoters hold around 46% and FIIs hold around 23.16% as on March 2025, according to the last available data on BSE. Public shareholding data shows that the retail investors' holding has declined from 9.99% in June 2023 to 7.69% in March 2025 (individual shareholders holding nominal share capital up to Rs 2 lakh) Live Events According to the last available data, Prashant Jain's 3P India Equity Fund held nearly 1.02% in Glenmark, while Ashish Dhawan held 1.77% in this stock. Mutual funds holding Mutual funds had around 4.16 crore shares of Glenmark Pharmaceuticals in May worth Rs 6,072 crore. Around 27 mutual fund houses had this stock in their portfolio as on May 31, 2025. Out of 27 AMCs, HDFC Mutual Fund and Mirae Asset Mutual Fund had the highest number of shares in their respective portfolios. HDFC Mutual Fund had around 1.27 crore shares of Glenmark Pharmaceuticals worth Rs 1,863 crore in May followed by Mirae Asset Mutual Fund which had 1.01 crore shares of this stock worth Rs 1,473 crore. Around 13 funds from HDFC Mutual Fund had this stock in their portfolio, of which HDFC Mid Cap Fund had the highest number of shares of around 87.78 lakh worth Rs 1,279 crore, followed by HDFC Manufacturing Fund which had 12 lakh shares of this stock worth Rs 174 crore. Around 17 funds from Mirae Asset Mutual Fund had exposure in this stock with Mirae Asset Large & Midcap Fund having the highest number of shares of 33.13 lakh worth Rs 482 crore. Mirae Asset Nifty Total Market Index Fund had the lowest number of shares of 319 in its portfolio. Also Read | How much money did ICICI Prudential's star fund manager Sankaran Naren make in FY25? Kotak Mutual Fund had 19.66 lakh shares of Glenmark Pharmaceuticals in its portfolio worth Rs 286 crore. Eight funds from the fund house had this stock in their portfolio and Kotak Arbitrage Fund had the highest number of shares of 13.48 lakh. SBI Mutual Fund , the largest mutual fund house based on assets managed, had 4.98 lakh shares of this stock worth Rs 72 crore, followed by Motilal Oswal Mutual Fund which had 2.49 lakh shares worth Rs 36.29 crore. PPFAS Mutual Fund had 3,575 shares in its portfolio worth Rs 0.52 crore. Angel One Mutual Fund and Unifi Mutual Fund which are new entrants in the mutual fund industry had around 453 and 325 shares of this stock in their respective portfolios. FII's holding According to the last available data, FII's holding showed a mixed trend. Smallcap World Fund, INC had 3.21% holding in this stock compared to 4.52% in June 2023. Government Pension Fund Global had 3.25% holding in March 2025 compared to 2.26% in June 2023. Ellipsis Partners LLC had 1.11% exposure in this stock compared to 1.68% in June 2023. Glenmark Pharmaceuticals step-down wholly owned subsidiary, Ichnos Glenmark Innovation (IGI), signed an exclusive global licensing agreement with US-based AbbVie for its experimental cancer drug, ISB 2001. ISB 2001, currently in Phase 1 clinical trials for relapsed or refractory multiple myeloma, will be jointly developed under the deal. AbbVie will hold exclusive rights to develop, manufacture, and commercialise the drug in North America, Europe, Japan, and China. Meanwhile, Glenmark will retain rights for Emerging Markets, including Asia (excluding Japan and China), Latin America, Russia/CIS, the Middle East, Africa, Australia, New Zealand, and South Korea. Under the agreement, IGI Therapeutics SA—a subsidiary of Ichnos Glenmark Innovation—will receive a $700 million upfront payment and is eligible for up to $1.225 billion in milestone payments, along with tiered, double-digit royalties on net sales.
Economic Times
11-07-2025
- Business
- Economic Times
Glenmark Pharmaceuticals shares rally up to 20%, mutual funds lead the charge over retail investors
The shares of Glenmark Pharmaceuticals surged 20% on Friday, July 11, to a day's high of Rs 2,286 following a landmark $2 billion licensing deal with U.S. pharma giant AbbVie for its cancer drug, ISB 2001. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Mutual funds holding Tired of too many ads? Remove Ads FII's holding The shares of Glenmark Pharmaceuticals surged 20% on Friday, July 11, to a day's high of Rs 2,286 following a landmark $2 billion licensing deal with U.S. pharma giant AbbVie for its cancer drug, ISB the announcement caught the attention of retail investors, the real winners were India's top mutual funds . pradeeAccording to the data on BSE, mutual fund holdings in Glenmark Pharma rose from 9.11% in June 2023 to 14.60% by March 2025 (the last available data).Also Read | Investors' pour Rs 47,000 crore in midcap & smallcap mutual funds in H1 CY25. What are they really chasing? Promoters hold around 46% and FIIs hold around 23.16% as on March 2025, according to the last available data on BSE. Public shareholding data shows that the retail investors' holding has declined from 9.99% in June 2023 to 7.69% in March 2025 (individual shareholders holding nominal share capital up to Rs 2 lakh)According to the last available data, Prashant Jain's 3P India Equity Fund held nearly 1.02% in Glenmark, while Ashish Dhawan held 1.77% in this funds had around 4.16 crore shares of Glenmark Pharmaceuticals in May worth Rs 6,072 crore. Around 27 mutual fund houses had this stock in their portfolio as on May 31, of 27 AMCs, HDFC Mutual Fund and Mirae Asset Mutual Fund had the highest number of shares in their respective portfolios. HDFC Mutual Fund had around 1.27 crore shares of Glenmark Pharmaceuticals worth Rs 1,863 crore in May followed by Mirae Asset Mutual Fund which had 1.01 crore shares of this stock worth Rs 1,473 13 funds from HDFC Mutual Fund had this stock in their portfolio, of which HDFC Mid Cap Fund had the highest number of shares of around 87.78 lakh worth Rs 1,279 crore, followed by HDFC Manufacturing Fund which had 12 lakh shares of this stock worth Rs 174 17 funds from Mirae Asset Mutual Fund had exposure in this stock with Mirae Asset Large & Midcap Fund having the highest number of shares of 33.13 lakh worth Rs 482 crore. Mirae Asset Nifty Total Market Index Fund had the lowest number of shares of 319 in its Read | How much money did ICICI Prudential's star fund manager Sankaran Naren make in FY25? Kotak Mutual Fund had 19.66 lakh shares of Glenmark Pharmaceuticals in its portfolio worth Rs 286 crore. Eight funds from the fund house had this stock in their portfolio and Kotak Arbitrage Fund had the highest number of shares of 13.48 lakh. SBI Mutual Fund , the largest mutual fund house based on assets managed, had 4.98 lakh shares of this stock worth Rs 72 crore, followed by Motilal Oswal Mutual Fund which had 2.49 lakh shares worth Rs 36.29 Mutual Fund had 3,575 shares in its portfolio worth Rs 0.52 crore. Angel One Mutual Fund and Unifi Mutual Fund which are new entrants in the mutual fund industry had around 453 and 325 shares of this stock in their respective to the last available data, FII's holding showed a mixed trend. Smallcap World Fund, INC had 3.21% holding in this stock compared to 4.52% in June 2023. Government Pension Fund Global had 3.25% holding in March 2025 compared to 2.26% in June 2023. Ellipsis Partners LLC had 1.11% exposure in this stock compared to 1.68% in June Pharmaceuticals step-down wholly owned subsidiary, Ichnos Glenmark Innovation (IGI), signed an exclusive global licensing agreement with US-based AbbVie for its experimental cancer drug, ISB 2001, currently in Phase 1 clinical trials for relapsed or refractory multiple myeloma, will be jointly developed under the deal. AbbVie will hold exclusive rights to develop, manufacture, and commercialise the drug in North America, Europe, Japan, and China. Meanwhile, Glenmark will retain rights for Emerging Markets, including Asia (excluding Japan and China), Latin America, Russia/CIS, the Middle East, Africa, Australia, New Zealand, and South the agreement, IGI Therapeutics SA—a subsidiary of Ichnos Glenmark Innovation—will receive a $700 million upfront payment and is eligible for up to $1.225 billion in milestone payments, along with tiered, double-digit royalties on net sales.
Hindustan Times
22-06-2025
- Health
- Hindustan Times
Spa therapy 101: Beginner's guide to calming massages, benefits and how to pick the right one for you
Stress has become a baseline in a world that's constantly on the move because the internalised hustle is quick to guilt-trip moments of break. Always 'a lot' is happening, whether it is chasing work deadlines, cramming leisure time with a little bit of everything, or overcomplicating self-care with 10-step skincare routines. Spa therapies are emerging as one of the grounding ways to truly pause, take a breath and unwind. But if you are new to it, the options can feel overwhelming, too, but we have simplified it for you. Spa therapies can help to cool your down.(Shutterstock) In an interview with HT Lifestyle, Megha Dinesh and Prashant Jain, co-founders, Meghavi Wellness Spa, unpacked what spa therapies have to offer. Spa therapies are becoming a calming reset button, a tranquil moment to unwind after long, hectic days. Addressing the rejuvenating benefits of these therapies, Megha said, 'From time-tested massages to transformative skin rituals, spa treatments offer a powerful way to feel recharged, relaxed, and completely reset, and sometimes deliver noticeable results from the very first session. Each therapy is designed not just to pamper, but to bring the body back to its natural state of harmony.' While spas are helpful to de-stress, they should not be mistaken as medical treatment, as Prashant added, "While these treatments don't replace clinical care, they offer an accessible gateway to regular wellbeing without downtime, prescriptions, or complexity.' Megha Dinesh and Prashant Jain shared a detailed yet simplified guide with us, outlining the key soothing massages and how it is done and how to identify if it is the right match for you: 1. Swedish Massage Swedish massage's strokes are gentle and long.(Shutterstock) How it is done: Swedish massage uses long, flowing strokes, gentle kneading, and circular motions to ease muscle tension, enhance circulation, and encourage full-body relaxation. Swedish massage uses long, flowing strokes, gentle kneading, and circular motions to ease muscle tension, enhance circulation, and encourage full-body relaxation. For whom it is ideal: Perfect for when you need to disconnect from a hectic week, this classic therapy uses long, flowing strokes to relax the body and ease everyday tension. Ideal for first-timers or anyone in need of a calming full-body experience, it's the equivalent of a mental reset button in physical form. 2. Deep tissue massage Deep tissue massage includes firmer and deeper strokes.(Shutterstock) How it is done: Deep tissue massage uses slow, firm pressure and deep strokes to reach the inner layers of muscles and connective tissue, helping to release chronic tension and stubborn muscle knots. Deep tissue massage uses slow, firm pressure and deep strokes to reach the inner layers of muscles and connective tissue, helping to release chronic tension and stubborn muscle knots. For whom it is ideal: If your body feels tight from too many hours at a desk or intense workouts, this therapy works into deeper muscle layers to release chronic tension. It's especially beneficial for active individuals or anyone feeling the effects of a high-stress lifestyle, bringing back flexibility and ease. 3. Hot stone therapy Warm stones are strategically placed in hot stone therapy. (Shutterstock) How it is done: Hot stone therapy involves placing warm basalt stones on specific points of the body and using them in massage to encourage deep muscle relaxation and boost blood circulation. Hot stone therapy involves placing warm basalt stones on specific points of the body and using them in massage to encourage deep muscle relaxation and boost blood circulation. For whom it is ideal: The perfect treatment for days when stress feels embedded in your bones. Heated stones are placed strategically to relax tight muscles and quiet the mind, making this a meditative experience that's as emotionally grounding as it is physically soothing. 4. Aromatherapy massage Aromatherapy massage utilises the power of essential oils and scents.(Shutterstock) How it is done: An aromatherapy massage combines soothing massage techniques with the healing properties of essential oils to relax the body, elevate the mood, and promote overall emotional and physical well-being. An aromatherapy massage combines soothing massage techniques with the healing properties of essential oils to relax the body, elevate the mood, and promote overall emotional and physical well-being. For whom it is ideal: For those seeking a more sensorial escape, this gentle massage blends essential oils like lavender or citrus to support mood and skin hydration. It's a multi-layered experience that not only smells divine but leaves you feeling balanced from the inside out. 5. Body wraps For body wraps, a special, soothing ingredient is smeared over teh targeted area and wrapped in thermal sheets,(Shutterstock) How it is done: Body wraps involve applying therapeutic ingredients such as mud, algae, or nourishing creams to the body, followed by wrapping in thermal sheets to help detoxify, hydrate, and firm the skin. Body wraps involve applying therapeutic ingredients such as mud, algae, or nourishing creams to the body, followed by wrapping in thermal sheets to help detoxify, hydrate, and firm the skin. For whom it is ideal: Great for a post-vacation reboot or pre-event polish, wraps made with seaweed, mud, or aloe help detoxify, tone, and deeply hydrate the skin. It results in a visible glow and that 'just-stepped-out-of-a-wellness-retreat' feeling in under an hour. 6. Facials Facials help alleviate skin fatigue.(Shutterstock) How it is done, types of facials: Using natural ingredients like honey, fruit enzymes, and clay, they deliver instant brightness, smoother texture, and a dose of feel-good confidence. Some popular types of facials, each designed to address specific skin concerns, include gold facials, wine facials, fruit facials, and more. Using natural ingredients like honey, fruit enzymes, and clay, they deliver instant brightness, smoother texture, and a dose of feel-good confidence. Some popular types of facials, each designed to address specific skin concerns, include gold facials, wine facials, fruit facials, and more. For whom it is ideal: Far from just a beauty ritual, modern facials address skin fatigue caused by pollution, blue light, and urban living. Massage therapy for back pain According to WebMD, massages offer relief in many ways, especially for back pain. Even a study hinted at the pain management effect of massage. The study was published in The Lancet Rheumatology in June 2025. However, the study's author noted that while massage may only assist with short-term symptom relief, it is not a long-term solution. For sustained pain management, treatment needs to be more holistic. This is why massage therapies should not be approached as a solution to a clinical problem. ALSO READ: Hot water baths to popping pimples: Dermatologist reveals biggest skincare mistakes you might be making Disclaimer: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
&w=3840&q=100)
Business Standard
16-06-2025
- Business
- Business Standard
HDFC Balanced Advantage becomes first hybrid fund to cross ₹1 tn AUM
HDFC Balanced Advantage Fund (BAF) has become the first hybrid mutual fund (MF) scheme in India to achieve the ₹1-trillion asset milestone. This achievement makes it the second actively managed MF scheme—after Parag Parikh Flexi Cap Fund—to reach this 13-digit assets under management (AUM) mark. Launched in February 1994, HDFC BAF has consistently been one of the most popular MF offerings, largely due to its steady performance and stable fund management. Despite experiencing two changes in the fund house, the scheme was managed by the same fund manager for the majority of its lifetime. Prashant Jain, who managed the scheme from its inception, holds the record for managing an MF scheme for the longest period in India—28 years. Initially known as Centurion Prudence Fund, the scheme was renamed Zurich India Prudence Fund in 1999 when Zurich India acquired 20th Century Mutual Fund. In 2003, HDFC AMC acquired Zurich India, leading to the scheme being renamed HDFC Prudence Fund. It became HDFC Balanced Advantage Fund in 2018 following the merger with HDFC Growth Fund. After Jain's departure from HDFC AMC in 2022, the scheme has been managed by Gopal Agarwal, Anil Bamboli and Srinivasan Ramamurthy. HDFC BAF has delivered over 18 per cent annualised returns on lump-sum investments since its inception. Systematic Investment Plan (SIP) investments have also yielded nearly 19 per cent returns. Currently, the scheme leads the balanced advantage category return chart across all time frames. As of 13 June, it delivered a 23 per cent annualised return over the three-year period and a 26 per cent annualised return over the five-year period, according to Value Research data. Gopal Agarwal attributes this performance to the scheme's model-driven approach. 'We follow a model-driven approach to asset allocation with focus on valuation metrics, macroeconomic insights and bottom-up stock selection. The model dynamically adjusts equity exposure based on changing market conditions, helping manage risk while aiming for long-term growth,' he said.
The Hindu
09-06-2025
- Business
- The Hindu
IIMB announces this year's Distinguished Alumni Awards
Sandhya Shekhar, Prashant Jain, Mathew Cyriac, and Vineet Saraiwala are the recipients of the Distinguished Alumni Awards given out by the Indian Institute of Management Bangalore (IIMB) to its alumni. The awards will be presented on June 15. The DAA is presented to alumni in recognition of their achievements of exceptional merit and excellence in their chosen field of endeavour. Each awardee receives a citation and her/his name is engraved on the Wall of Fame in IIMB. Ms. Shekhar, (PGP 1984), is an advisor and strategy consultant to several corporate entities in the areas of business strategy and digital transformation and serves as an independent director on the governing boards of many companies. Mr. Jain, (PGP 1991), founder and chief investment officer of 3P Investment Managers, has 31 years of investment management. He holds the distinction of being the only fund manager in India and one of the few globally, to have continuously managed a scheme for over 28 years (HDFC Balanced Advantage Fund), and the first fund manager in India to have managed 1 lakh crore of equity funds. Mr. Cyriac, (PGP 1994) whose career spans over 30 years has been recognised for many firsts during his investing roles in India and the U.S.. He is now the executive chairman of the PE firm Florintree Advisors and co-founder at deep tech fund Yali Capital. Mr. Saraiwala (PGP 2015) is the founder and CEO of Atypical Advantage which has influenced corporate India's approach towards disability inclusion as a business imperative. The organisation received both the National Startup Award for Social Impact and the National Award for Best Placement Organisation presented by the President of India, in 2024. IIMB will also host the orientation for the incoming cohort of its two-year fulltime MBA programmes, PGP and PGPBA, 2025-2027 batch, on June 9.
